These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24843673)

  • 21. The Hidden Link between Polycystic Ovary Syndrome and Kidney Stones: Finding from the Tehran Lipid and Glucose Study (TLGS).
    Rostami Dovom M; Rahmati M; Amanollahi Soudmand S; Ziaeefar P; Azizi F; Ramezani Tehrani F
    Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685351
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The complex relationship between hypothalamic amenorrhea and polycystic ovary syndrome.
    Wang JG; Lobo RA
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1394-7. PubMed ID: 18230664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.
    Song DK; Oh JY; Lee H; Sung YA
    Korean J Intern Med; 2017 Jul; 32(4):690-698. PubMed ID: 27899014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Can we use serum Anti-Mullerian hormone to differentiate the diagnosis between polycystic ovary syndrome patients and healthy women with polycystic ovarian morphology and regular menstrual cycles.
    Aydoğmuş H; Kelekçi S; Elmalı F; Aydoğmuş S
    Saudi Med J; 2018 Oct; 39(10):1011-1016. PubMed ID: 30284584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-Müllerian hormone as a diagnostic tool for PCOS under different diagnostic criteria in an unselected population.
    Bozdag G; Mumusoglu S; Coskun ZY; Yarali H; Yildiz BO
    Reprod Biomed Online; 2019 Sep; 39(3):522-529. PubMed ID: 31182353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
    Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
    Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
    [No Abstract]   [Full Text] [Related]  

  • 27. Effects of long-term exogenous testosterone administration on ovarian morphology, determined by transvaginal (3D) ultrasound in female-to-male transsexuals.
    Caanen MR; Schouten NE; Kuijper EAM; van Rijswijk J; van den Berg MH; van Dulmen-den Broeder E; Overbeek A; van Leeuwen FE; van Trotsenburg M; Lambalk CB
    Hum Reprod; 2017 Jul; 32(7):1457-1464. PubMed ID: 28505246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current diagnosis of polycystic ovary syndrome: expanding the phenotype but generating new questions].
    Merino P; Schulin-Zeuthen C; Codner E
    Rev Med Chil; 2009 Aug; 137(8):1071-80. PubMed ID: 19915773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in Clinical Presentation, Metabolic Profile, Hormonal Parameters and Inflammatory Markers in Polycystic Ovary Syndrome Women with and without Polycystic Ovary Morphology Appearance.
    Jena S; Mishra I; Baliarsinha AK; Jena D; Debata M
    J Hum Reprod Sci; 2023; 16(2):132-139. PubMed ID: 37547087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hirsutism and oligomenorrhea are appropriate screening criteria for polycystic ovary syndrome in adolescents.
    Villarroel C; López P; Merino PM; Iñiguez G; Sir-Petermann T; Codner E
    Gynecol Endocrinol; 2015; 31(8):625-9. PubMed ID: 26190534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Each small antral follicle in ovaries of women with polycystic ovary syndrome produces more antimüllerian hormone than its counterpart in a normal ovary: an observational cross-sectional study.
    Bhide P; Dilgil M; Gudi A; Shah A; Akwaa C; Homburg R
    Fertil Steril; 2015 Feb; 103(2):537-41. PubMed ID: 25467043
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The relationship of serum anti-Mullerian hormone with polycystic ovarian morphology and polycystic ovary syndrome: a prospective cohort study.
    Homburg R; Ray A; Bhide P; Gudi A; Shah A; Timms P; Grayson K
    Hum Reprod; 2013 Apr; 28(4):1077-83. PubMed ID: 23377771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A rational approach to the diagnosis of polycystic ovarian syndrome during adolescence.
    Merino PM; Codner E; Cassorla F
    Arq Bras Endocrinol Metabol; 2011 Nov; 55(8):590-8. PubMed ID: 22218441
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of Adolescents with Differing Polycystic Ovary Syndrome Phenotypes.
    Fitzgerald S; Stamoulis C; Gooding HC; DiVasta AD
    J Pediatr Adolesc Gynecol; 2020 Dec; 33(6):697-702. PubMed ID: 32889085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevation of markers of endotoxemia in women with polycystic ovary syndrome.
    Banaszewska B; Siakowska M; Chudzicka-Strugala I; Chang RJ; Pawelczyk L; Zwozdziak B; Spaczynski R; Duleba AJ
    Hum Reprod; 2020 Oct; 35(10):2303-2311. PubMed ID: 32869098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterizing discrete subsets of polycystic ovary syndrome as defined by the Rotterdam criteria: the impact of weight on phenotype and metabolic features.
    Welt CK; Gudmundsson JA; Arason G; Adams J; Palsdottir H; Gudlaugsdottir G; Ingadottir G; Crowley WF
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4842-8. PubMed ID: 17003085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polycystic ovarian morphology in Thai women of reproductive age with polycystic ovary syndrome.
    Wongwananuruk T; Chantrapanichkul P; Unalome V; Indhavivadhana S; Rattanachaiyanont M; Techatraisak K; Angsuwathana S; Silprasit K
    Asian Biomed (Res Rev News); 2020 Dec; 14(6):271-277. PubMed ID: 37551303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of the newly recommended antral follicle count cutoff for polycystic ovary in adult women with polycystic ovary syndrome.
    Kim JJ; Hwang KR; Chae SJ; Yoon SH; Choi YM
    Hum Reprod; 2020 Mar; 35(3):652-659. PubMed ID: 32211797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Criteria for polycystic ovarian morphology in polycystic ovary syndrome as a function of age.
    Alsamarai S; Adams JM; Murphy MK; Post MD; Hayden DL; Hall JE; Welt CK
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4961-70. PubMed ID: 19846740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum anti-Mullerian hormone levels in the main phenotypes of polycystic ovary syndrome.
    Sahmay S; Atakul N; Oncul M; Tuten A; Aydogan B; Seyisoglu H
    Eur J Obstet Gynecol Reprod Biol; 2013 Sep; 170(1):157-61. PubMed ID: 23806449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.